Abstract:
Objective To screen and analyze the differentially expressed genes of breast cancer and normal breast tissues in young women using bioinformatics method,and explore their related molecular mechanisms.
Methods The transcriptome data of young women (≤35 years old) with breast cancer were downloaded from TCGA Database,including 29 breast tumor tissue samples and 3 normal breast tissue samples.Then the differentially expressed genes were screened by Limma package in R language,the protein interaction network of differentially expressed genes coding was constructed through STRING Database,and the biological functions and signal pathways of up-regulated core genes were mainly analyzed.
Results A total of 720 differentially expressed genes were screened out,including 173 up-regulated genes and 547 down-regulated genes.The core genes obtained through the protein interaction analysis included NCAPG,NCAPH,MELK,PBK,CDCA5,CDCA8,CCNB2,CCNA2,SPC25,SKA1,NPY1R,CXCL9,CXCL10,GALR2,CCR8,CXCL2,CXCL3,CXCL5,PPBP,and CCL16.Among them,15 core genes with up-regulated expression in breast cancer of young women were NCAPG,NCAPH,MELK,PBK,CDCA5,CDCA8,CCNB2,CCNA2,SPC25,SKA1,NPY1R,CXCL9,CXCL10,GALR2 and CCR8;5 core down-regulated genes were CXCL2,CXCL3,CXCL5,PPBP and CCL16,and they were rarely reported in previous studies.The GO analysis showed that up-regulated core genes were highly correlated with biological processes such as mitosis,positive cell proliferation regulation,and immune response.Moreover,up-regulated core genes were closely correlated with KEGG signal pathways such as chemokine signal pathway and neuroactive ligand-receptor interaction.
Conclusion This study has screened out 20 potential core genes of breast cancer in young women based on bioinformatics method,and analyzed the biological functions and signal pathways of up-regulated expression core genes.The findings contribute to a theoretical basis for the further understanding of the molecular mechanisms related to breast cancer in young women,and provide theoretical guidance to clinical diagnosis and treatment.